In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. argenx SE is one of them. argenx SE (NASDAQ:ARGX) is strengthening its leadership in autoimmune therapies with the rapid expansion of Vyvgart, its flagship antibody-based treatment. Available in both intravenous and subcutaneous forms, Vyvgart has become a cornerstone therapy for generalized myasthenia gravis (gMG) and is now extending its reach into other autoimmune diseases, including immune thrombocytopen ...

We recently published AI Frenzy: 10 Stocks Crushing the Market, 6 Climb to Fresh Highs. Sable Offshore Corp. (NYSE:SOC) is one of the top performers on Wednesday. Sable Offshore snapped a three-day losing streak on Wednesday, jumping 22.58 percent to close at $24.59 apiece as investors repositioned portfolios on optimism for the Las Flores pipeline’s restart this month. It can be recalled that Sable Offshore Corp. (NYSE:SOC), in an updated report last August, announced targets of recommencing oil sales u ...

Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. The fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) delivered 3.06% and 3.10%, respectively, in the second quarter of 2025 compared to a 3.79% return for the Russell 1000 Value Index (Russell Value) and 10.94% return for the Standard & Poor 500 Index (S&P 500). Sound Shore’s 35-year annualized returns were 14.92% and 15.14% for SSH ...

Larry Ellison passes Elon Musk as world's richest person, IPO mania returns, Labor Department investigates federal statistics gathering, and more news to start your day. ...